Abstract
intestinal TJ barrier; allowing increased paracellular permeation of noxious luminal antigens that induce inflammatory response
. TNF-␣, at physiologically relevant concentrations (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) ng/ml), causes an increase in intestinal TJ permeability, manifested by an increase in epithelial permeability to paracellular markers and a drop in transepithelial resistance [32, 34, [37] [38] [39] [40] . Previous studies have shown that the TNF-␣-induced increase in Caco-2 intestinal epithelial TJ permeability was regulated by an increase in MLCK gene and protein expression [32, 41] 
; and inhibition of TNF-␣-induced increase in MLCK transcription or protein expression prevented the TNF-␣ increase in intestinal TJ permeability.
Recent animal studies have shown that MLCK plays a central role in immune, stress or bacterial endotoxin-mediated increase in intestinal permeability and subsequent inflammatory response [28, 29, [42] [43] [44] . In these studies, the increase in intestinal permeability in mice was associated with an increase in intestinal MLCK gene and protein expression [28, 29, [42] [43] [44] ; and the inhibition of MLCK activity with known pharmacologic inhibitors including ML-7 or PIK prevented the increase in intestinal TJ permeability. [29, 42, 44] . [45] . These studies suggested that the increase in MLCK protein expression and activity contributes to the intestinal permeability increase in animals and humans; and MLCK has been identified as a potential therapeutic target to induce re-tightening of intestinal TJ barrier in inflammatory conditions [28, 29, [42] [43] [44] [45] .
Moreover, the pharmacologic inhibition of MLCK activity and increase in intestinal TJ permeability prevented the subsequent development of intestinal inflammation in mice

Human studies have also shown that patients with CD have an increase in MLCK protein expression. The increase in MLCK protein expression in CD intestinal tissue directly correlated with the level of intestinal inflammation
In previous studies, we have identified and cloned a functionally active MLCK promoter region [46] . These studies have shown that TNF-␣-induced increase in Caco-2 TJ permeability was mediated by an increase in MLCK gene activity and gene transcription, MLCK protein expression and activity [46] . 
However, the intracellular and molecular mechanisms that mediate the basal and TNF-␣-induced increase in MLCK gene activity and subsequent increase in MLCK protein expression remain unclear. The major aim of this study was to elucidate the cellular and molecular mechanisms that regulate the basal and TNF-␣-induced increase in MLCK gene activity and the subsequent increase in MLCK protein expression, using filter-grown Caco-2 intestinal epithelial cells. In the first part of this study, we identified the minimal MLCK promoter region and the essential molecular determinants that regulate the basal MLCK promoter activity in Caco-2 monolayers. In the second part, we identified the molecular determinants and the molecular processes that mediate the TNF-␣-induced increase in MLCK promoter activity and protein expression. These studies provide novel insight into cellular and molecular mechanisms that mediate the basal and TNF-␣-induced increase in MLCK gene activity and protein expression.
Materials and methods
Materials
Cell cultures
FL-MLCK(+) GCCGGTACCGAGAAGCAGGAGAGTATTAAATG
FL-MLCK(-) CCAAGCTTATGTTTGTTGTGGCAACTGGGC
MLCK-1628(+) CGGGGTACCTCTTCAAGGTCAAGAGATGTC
MLCK-929(+) CGGGGTACCCTCTGCCCTCTTGACTTAATC
MLCK-509(+) GATGGTACCTGAAGGTAGGAGAGACACTC
MLCK-313(+) GCCGGTACCATGGCCTTCCTCCCTCACCCCT
MLCK-245(+) CGGGGTACCTGAGTACCACCGTCATGGTTC
MLCK-76(+) CGGGGTACCTGTCCCAGAGTGATGTACTCC
MLCK+46(+) GCCGGTACCAGTTCAGAGCAACTTCAGGAG
MLCK+66(+) GCCGGTACCAGAGCTTCAGGACGCCTTTC
Luciferase assay
After the TNF-␣ treatment (7 hrs) [47] 
Determination of Caco-2 epithelial monolayer resistance
The effect of TNF-␣ on Caco-2 monolayer epithelial electrical resistance was measured using epithelial volt-ohmmeter (World Precision Instruments, Sarasota, FL, USA) as previously described [48, 49] (Fig. 1A) .
Statistical analysis
Identification of MLCK minimal promoter region
Previously, we cloned a 2091 bp MLCK promoter region (Genbank accession number DQ 090939) into a pGL3 basic vector [46] . The sequence of the full-length (FL) 2091 bp MLCK promoter region is shown in Figure 1B . In the following studies, we determined the minimal promoter region. For this purpose, a progressively increasing 5Ј deletion constructs were generated (total of eight) and subcloned into the pGL3 basic vector (Fig. 2) . Deletion constructs were then transfected into confluent Caco-2 cells and the promoter activity determined by luciferase assay (Fig. 2) . As shown in Fig. 2 (Fig. 2) . The deletion of 5Ј end extending beyond -246 resulted in a marked decrease in promoter activity. Based on these results, we identified -313 to ϩ118 as a minimal MLCK promoter region.
, progressive deletion of 5Ј end extending to -314 did not result in a significant increase in promoter activity compared to the FL promoter (2091 bp). The deletion construct MLCK -313 exhibited a 2-fold increase in promoter activity compared to the FL promoter
Regulation of basal MLCK promoter activity
As shown in Figure 2, (Fig. 3) . It should be noted that the basal promoter activity of the p53 mutant MLCK promoter was similar to deletion construct MLCK -245 (which lacks the p53 binding region) (Fig. 2) (Fig. 4) . The deletion of 8 bp start sequence resulted in a significant decrease in luciferase activity (Fig. 4) . To further narrow the start site, a four base pair mutant which replaces CCAC (-2 to ϩ2) with TTGT was generated. The 4 bp mutation also resulted in a similar decrease in luciferase activity as the 8 bp deletion construct (Fig. 4) , suggesting that transcription start site (TSS) was located within this four base pair sequence. To determine the role of DPE in basal gene transcription process, a double mutation of the TSS and DPE was generated. The double mutation resulted in almost complete absence of the promoter activity (Fig. 4) , confirming that these two sites were essential for the initiation of MLCK gene transcription.
NF-B regulation of MLCK promoter activity
Previously, we reported that TNF-␣-induced increase in MLCK gene transcription was mediated by nuclear transcription factor NF-B [32] activity of deletion constructs having progressively larger 5Ј end deletion was determined. As shown in Fig. 5 (Fig. 7) . (Fig. 2) , suggesting that the NF-B2 site may have a repressive effect on promoter activity. To investigate the possible interactive relationship between NF-B1 and 2 site, the effect of NF-B1 site mutation in the presence of NF-B2 site was determined using MLCK -509 (which contains the NF-B1 and 2 sites) (Fig. 8) . The mutation of NF-B1 site resulted in a marked decrease in MLCK -509 promoter activity (Fig. 8A) . These results
, TNF-␣ caused a significant increase in MLCK promoter activity in the FL MLCK promoter construct compared to the control (P Ͻ 0.05). TNF-␣ also caused a similar proportional increase in MLCK promoter activity in the deletion constructs lacking the NF-B2 to 8 sites (Fig. 5B and C), indicating that NF-B2 to 8 sites were not necessary for the TNF-␣-induced up-regulation of MLCK promoter activity. These findings suggested that the NF-B1 site (located within the minimal region) may be the regulatory site that mediated the TNF-␣-induced up-regulation of MLCK promoter activity. To test this possibility, NF-B1 motif was mutated in MLCK -313. In the wild-type MLCK-313, TNF-␣ caused an increase in MLCK promoter activity (Fig. 6A). The mutation of the NF-B1 site completely prevented the TNF-␣-induced increase in promoter activity (Fig. 6A). In separate studies, the effect of NF-B1 mutation on FL MLCK promoter activity was also determined. The mutation of the NF-B1 site in the FL MLCK also prevented the TNF-␣-induced increase in promoter activity (Fig. 6B). These results indicated that the NF-B1 site was required for the TNF-␣-induced increase in promoter activity. Next, the binding of TNF-␣ activated NF-B to the NF-B1 binding site on MLCK promoter region was determined using an ELISA-based DNA-binding assay. In these studies, 50 bp doublestranded DNA probe encoding the NF-B1 site (30 bp up-and 10 bp downstream of NF-B1 site) on MLCK promoter region was synthesized and used as a probe to assess the binding of NF-B to the NF-B1 motif. The nuclear extracts from control and TNF-␣ treated Caco-2 monolayers were used to assess the binding of NF-B to the DNA probe. TNF-␣ treatment resulted in a significant increase in NF-B binding to the NF-B1 binding site on the DNA probe (Fig. 6C). The mutation of NF-B1 binding site on DNA probe prevented the TNF-␣ increase in NF-B binding to the DNA probe (Fig. 6C). These findings confirmed that TNF-␣ causes an increase in NF-B binding to the NF-B1 binding motif, which presumably leads to the activation of MLCK promoter.
p53 binding site does not play a role in TNF-␣-induced increase in MLCK promoter activity
Above studies indicated that the p53 site (-294 to -275) plays a crucial role in basal MLCK promoter activity. The possible involvement of this site in mediating the TNF-␣ modulation of MLCK promoter activity was also examined by site-directed mutagenesis of p53 binding motif. The mutation of p53 binding site did not inhibit the TNF-␣-induced increase in MLCK promoter activity
Although the basal promoter activity in the p53 mutant promoter was lower, there was a similar proportional increase in MLCK promoter activity in response to TNF-␣ treatment in both the WT MLCK -313 and p53 mutant constructs. These findings suggested that although p53 site plays a crucial role in the regulation of basal promoter activity, this site was not involved in mediating the TNF-␣ regulation of MLCK promoter activity.
Molecular mechanisms of TNF-␣ regulation of MLCK promoter activity
To delineate the molecular mechanisms involved in NF-B regulation of MLCK promoter activity, the role of NF-B1 and 2 sites in the regulation of MLCK promoter activity was examined. As shown in Fig. 2, deletion of six upstream NF-B sites (NF-B3 to 8) between -1973 and -509 did not affect the basal MLCK promoter activity. However, extending the deletion to include NF-B2 site between -325 and -316 resulted in a 2-fold increase in basal promoter activity
suggested that NF-B1 and 2 sites may have opposite regulatory actions on MLCK promoter activity; NF-B2 site appears to suppress while NF-B1 site appears to up-regulate the MLCK promoter activity. To further examine this issue, subsequent studies, the regulatory response of NF-B1 and 2 sites to TNF-␣ stimulation was examined. TNF-␣ treatment resulted in a significant increase in promoter activity of MLCK -509. In mutant MLCK -509 (with mutated NF-B1 site), TNF-␣ treatment resulted in a decrease in MLCK promoter activity, suggesting that in response to TNF-␣ treatment NF-B2 site down-regulates the promoter activity. Previous studies have shown that different NF-B dimers have varying regulatory action on gene regulation. NF-B p50/p65
dimers are known to activate gene activity while p50/p50 dimers have been shown to repress gene activity [52] [53] [54] [55] Fig. 9A , TNF-␣ (10 ng/ml) treatment resulted in a marked increase in NF-B p50/p65 heterodimer binding to 32 (Fig. 9B ). In contrast, TNF-␣ caused a significant increase in p50 binding but did not cause an increase in p65 binding to the NF-B2 site (Fig. 9C) Figure 10A, (Fig. 10B) , confirming that p50/p65 was not involved in the NF-B2 site down-regulation of promoter activity. The NF-B p65 silencing also inhibited the TNF-␣-induced increase in MLCK protein expression, indicating that p50/p65 mediated the TNF-␣ increase in MLCK protein expression (Fig. 10C) . Moreover, NF-B p65 silencing also prevented the TNF-␣-induced drop in Caco-2 transepithelial resistance (Fig. 10D) [57] . The p50/p65 and p50/p50 dimers are the most common dimer types in cells [58] [59] [60] . It has been shown that p50 and p65 subunits are ubiquitously expressed in various cell types [58] [59] [60] . The p50/p65 is the predominant dimer type (Ͼ90%) and p50/p50 is a minor dimer type present in cells [61] [62] [63] . The basal expression of other family members varies greatly and their presence depends on the specific cell type.
Fig. 4 Effect of transcription start site (TSS) or downstream promoter element (DPE) site mutation on minimal MLCK promoter activity. Constructs containing either 8 bp deletion or 4 bp mutation of TSS and double mutation of TSS and DPE sites were generated as described in
Fig. 5 TNF-␣ (10 ng/ml) effect on MLCK promoter activity in deletion constructs containing decreasing numbers of NF-B sites. (A) FL MLCK promoter (containing 8 B sites); (B) MLCK -929 (containing 4 B sites); (C) MLCK -313 (containing only the NF-B1 site). Data are represented as mean of four replicates Ϯ S.E. *P Ͻ 0.05 compared to control.
Fig. 6 NF-B1 binding site on MLCK promoter is required for the TNF-␣-induced increase in MLCK promoter activity. (A) TNF-␣ effect on MLCK promoter activity in promoter construct MLCK -313 having either intact or mutated NF-B1 binding site. (B) TNF-␣ effect on FL MLCK promoter activity in promoter construct having either intact or mutated NF-B1 binding site. (C) TNF-␣ effect on NF-B binding to
corresponding to the NF-B1 region and 5Ј-TGCAGGAAG-GCAGCTCCCATGGCCT-3Ј corresponding to the NF-B2 region). As shown in
p65 siRNA transfection resulted in a near-complete depletion of NF-B p65 in Caco-2 monolayers. NF-B p65 silencing resulted in a complete inhibition of TNF-␣-induced increase in MLCK promoter activity in MLCK -313 (Fig. 10B), indicating that NF-B p65 was required for the NF-B1 site up-regulation of promoter activity. In contrast, NF-B p65 siRNA did not affect the TNF-␣-induced decrease in promoter activity in MLCK -509 Mu (which contains functionally active NF-B2 site, but a mutated NF-B1 site)
In this study, we examined the regulatory actions of two B sites; within (NF-B1: ϩ48 to ϩ57) and external (NF-B2: -325 to -316) to the minimal promoter region (Fig. 1B) . Interestingly, our data indicated that the two B sites had opposite effects on promoter activity (Fig. 8) [64, 65] . In contrast, p50 lacks the transactivation domain and functions only in DNA binding [64] . The p50/p50 dimers have been shown to act as a negative regulator of NF-B activity by competing with p50/p65 for the NF-B response elements [65] . The p50/p50 homodimers preferentially bind to the GC rich binding sites in comparison to p50/p65 dimers [66] . Consistent with this, our data showed that p50/p50 dimers have higher affinity to (Fig. 10) [46] . Our data suggested an interesting possibility that during quiescent (unstimulated) 
